Scarica l'app Stockscreener
5.36
0.74%
-0.04
Dopo l'orario di chiusura:
5.36
Precedente Chiudi:
$5.40
Aprire:
$5.45
Volume 24 ore:
20,239
Relative Volume:
1.78
Capitalizzazione di mercato:
$192.74M
Reddito:
-
Utile/perdita netta:
$-25.50M
Rapporto P/E:
-6.961
EPS:
-0.77
Flusso di cassa netto:
$-30.10M
1 W Prestazione:
+1.71%
1M Prestazione:
-0.37%
6M Prestazione:
+48.48%
1 anno Prestazione:
+118.78%
Intervallo 1D:
$5.30
$5.45
Intervallo di 1 settimana:
$5.12
$5.4793
Portata 52W:
$2.20
$6.1999
Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile
Nome
Eupraxia Pharmaceuticals Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta EPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EPRX
Eupraxia Pharmaceuticals Inc
|
5.36 | 194.54M | 0 | -25.50M | -30.10M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-26 | Iniziato | H.C. Wainwright | Buy |
| 2025-06-16 | Iniziato | Canaccord Genuity | Speculative Buy |
| 2025-02-21 | Iniziato | Craig Hallum | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
Eupraxia Pharmaceuticals Inc Borsa (EPRX) Ultime notizie
Bull Bear: Can Eupraxia Pharmaceuticals Inc. maintain its current growth rateQuarterly Profit Report & AI Enhanced Trading Alerts - khodrobank.com
Does Eupraxia Pharmaceuticals Inc. stock benefit from AI growthDividend Hike & AI Based Trade Execution Alerts - khodrobank.com
Should you sell your Eupraxia Pharmaceuticals stock? - Cantech Letter
Eupraxia Pharmaceuticals Inc. stock trend outlook and recovery pathRisk Management & Technical Confirmation Alerts - Newser
Published on: 2025-09-03 06:15:10 - Newser
How to interpret RSI for Eupraxia Pharmaceuticals Inc. stockJuly 2025 Intraday Action & High Yield Stock Recommendations - Newser
Earnings visualization tools for Eupraxia Pharmaceuticals Inc.2025 Geopolitical Influence & Reliable Volume Spike Alerts - Newser
Smart tools for monitoring Eupraxia Pharmaceuticals Inc.’s price actionInsider Selling & AI Powered Trade Plan Recommendations - Newser
Is Eupraxia Pharmaceuticals Inc. trending in predictive chart modelsWeekly Trade Summary & Real-Time Buy Signal Notifications - Newser
Market reaction to Eupraxia Pharmaceuticals Inc.’s recent newsJuly 2025 Big Picture & Smart Swing Trading Alerts - Newser
Understanding Eupraxia Pharmaceuticals Inc.’s price movement2025 Breakouts & Breakdowns & Verified Entry Point Detection - Newser
Leading vs lagging indicators on Eupraxia Pharmaceuticals Inc. performanceMarket Sentiment Report & Real-Time Buy Signal Notifications - Newser
Published on: 2025-09-03 02:09:55 - Newser
How to manage a losing position in Eupraxia Pharmaceuticals Inc.Market Weekly Review & Fast Exit/Entry Strategy Plans - Newser
What technical models suggest about Eupraxia Pharmaceuticals Inc.’s comebackDollar Strength & Stepwise Entry and Exit Trade Signals - Newser
Is Eupraxia Pharmaceuticals Inc. in a bullish channel2025 Support & Resistance & Momentum Based Trading Ideas - khodrobank.com
First Set of 1-Year Clinical Results from RESOLVE Trial in - GlobeNewswire
Eupraxia Pharmaceuticals shares rise 10.91% after-hours following positive 1-year clinical results from RESOLVE trial. - AInvest
Sentiment Recap: Will Eupraxia Pharmaceuticals Inc. outperform during market ralliesMarket Volume Report & AI Driven Stock Movement Reports - khodrobank.com
Earnings Report: Is Eupraxia Pharmaceuticals Inc. in a bullish channel2025 Historical Comparison & Expert Curated Trade Setups - khodrobank.com
Can Eupraxia Pharmaceuticals Inc. outperform under higher oil pricesJuly 2025 EndofMonth & Verified Short-Term Trading Plans - khodrobank.com
Research Solutions, Inc. shares rise 2.64% intraday after Eupraxia Pharmaceuticals Inc. reported positive clinical trial results. - AInvest
Update Recap: Will Eupraxia Pharmaceuticals Inc. benefit from rate cutsLayoff News & Weekly High Conviction Ideas - khodrobank.com
Published on: 2025-09-02 10:22:34 - Newser
Eupraxia Pharmaceuticals Reports Promising 1-Year Results for EoE Treatment - TipRanks
One-Year Treatment Success: Eupraxia's Once-Yearly EoE Drug Maintains 67% Patient Remission in Clinical Trial - Stock Titan
Published on: 2025-09-02 06:56:07 - Newser
What are the future prospects of Eupraxia Pharmaceuticals Inc.Swing Trade & Intraday High Probability Alerts - khodrobank.com
Will Eupraxia Pharmaceuticals Inc. price bounce be sustainableJuly 2025 Market Mood & Risk Controlled Daily Trade Plans - Newser
What is the next catalyst for Eupraxia Pharmaceuticals Inc.Share Buyback & Fast Gain Swing Trade Alerts - khodrobank.com
Eupraxia Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Volume & Reliable Price Breakout Alerts - Newser
What’s the outlook for Eupraxia Pharmaceuticals Inc.’s sectorJobs Report & Safe Entry Zone Identification - khodrobank.com
What is the earnings history of Eupraxia Pharmaceuticals Inc.Weekly Stock Analysis & Daily Profit Focused Stock Screening - khodrobank.com
How hedge fund analytics apply to Eupraxia Pharmaceuticals Inc. stock2025 Price Momentum & Low Drawdown Momentum Trade Ideas - Newser
Is Eupraxia Pharmaceuticals Inc. showing signs of accumulationJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - Newser
Can Eupraxia Pharmaceuticals Inc. maintain its current growth rateJuly 2025 Weekly Recap & Weekly Watchlist of Top Performers - khodrobank.com
Is Eupraxia Pharmaceuticals Inc. stock entering bullish territoryMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - Newser
What candlestick patterns are forming on Eupraxia Pharmaceuticals Inc.CPI Data & Community Consensus Stock Picks - Newser
What data driven models say about Eupraxia Pharmaceuticals Inc.’s futureWeekly Trend Summary & Risk Controlled Daily Trade Plans - Newser
Eupraxia Pharmaceuticals Inc. stock retracement – recovery analysisQuarterly Portfolio Summary & Daily Chart Pattern Signals - Newser
Does Eupraxia Pharmaceuticals Inc. show high probability of rebound2025 Trade Ideas & Fast Gain Stock Tips - Newser
How to build a custom watchlist for Eupraxia Pharmaceuticals Inc.Dip Buying & Daily Price Action Insights - Newser
How to use Fibonacci retracement on Eupraxia Pharmaceuticals Inc.Fed Meeting & Target Return Focused Stock Picks - Newser
Can Eupraxia Pharmaceuticals Inc. hit a new high this monthPortfolio Gains Report & Consistent Income Trade Ideas - Newser
Evaluating Eupraxia Pharmaceuticals Inc. with trendline analysis2025 Market WrapUp & Daily Price Action Insights - Newser
Can trapped investors hope for a rebound in Eupraxia Pharmaceuticals Inc.Weekly Profit Recap & Weekly Watchlist of Top Performers - Newser
Eupraxia Pharmaceuticals Inc Azioni (EPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):